Iovance Biotherapeutics, Inc. IOVA Total costs & expenses

Total costs & expenses at other companies

Bristol-Myers SquibbBMY

$8.89B-15.3%

Gilead SciencesGILD

$18.2B+295%

ImmunityBio, Inc.IBRX

$114M+40.8%

IncyteINCY

$976.14M+42.5%

Intellia TherapeuticsNTLA

$120.42M-3.1%

FAQ

What is Iovance Biotherapeutics, Inc.'s total costs & expenses?

Iovance Biotherapeutics, Inc. (IOVA) reported total costs & expenses of $151.22M in Q2 2026.

How has Iovance Biotherapeutics, Inc.'s total costs & expenses changed year-over-year?

Iovance Biotherapeutics, Inc.'s total costs & expenses decreased by 13.0% year-over-year, from $173.73M to $151.22M.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s total costs & expenses?

Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s total costs & expenses has grown at a 18.1% compound annual growth rate (CAGR), from $342.7M to $666.86M.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating and non-operating costs incurred by the company during a reporting period. It encompasses cost of revenue, research and development, general and administrative expenses, and other operational charges. Monitoring this figure is essential for assessing the company's overall burn rate and operational efficiency as it scales toward commercialization.